These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 358140)

  • 21. [Comparison of dihydroergotoxine and placebo in the treatment of moderate arterial hypertension in older persons].
    Bagatin J; Rumboldt Z; Jurisić M; Vujić D
    Med Pregl; 1988; 41(1-2):74-7. PubMed ID: 3054457
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of a levo-5-hydroxytryptophan-dihydroergocristine combination on depression and neuropsychic performance: a double-blind placebo-controlled clinical trial in elderly patients.
    Rousseau JJ
    Clin Ther; 1987; 9(3):267-72. PubMed ID: 3111702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Controlled double-blind study of the clinical equivalent of two posologic regimens of Hydergine: 1 x 4,5mg compared to 3 x 1,5mg per day].
    Piguet PV; Zoufal Z
    Rev Med Suisse Romande; 1981 Feb; 101(2):157-63. PubMed ID: 7015453
    [No Abstract]   [Full Text] [Related]  

  • 24. [Controlled study of the effect of dihydroergocristine on organic brain psychosyndrome].
    Aranda B; Dumoulin P; Groothold G
    Arzneimittelforschung; 1992 Nov; 42(11A):1406-9. PubMed ID: 1492863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Dynamic study of osmotic resistance of red cells in sickle cell anemia (author's transl)].
    Juhan I; Isnard G; Aquaron R
    Pathol Biol (Paris); 1976 Sep; 24(7):451-5. PubMed ID: 790270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of organic brain psychosyndrom in the old age. A double blind study with Hydergin (author's transl)].
    Biel ML; Seus R; Struppler A
    Med Klin; 1976 Dec; 71(49):2177-84. PubMed ID: 794665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Co-dergocrinmesylate in elderly hypertensive patients].
    Bock KD; Welzel D; Dennler HJ
    MMW Munch Med Wochenschr; 1982 Dec; 124(48):1095-8. PubMed ID: 6817133
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of N-acetylcysteine on dense cell formation in sickle cell disease.
    Pace BS; Shartava A; Pack-Mabien A; Mulekar M; Ardia A; Goodman SR
    Am J Hematol; 2003 May; 73(1):26-32. PubMed ID: 12701116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical profile of sickle cell homozygote patient after the age of 30 years].
    Elira Dokekias A; Nzingoula S
    Tunis Med; 2003 Feb; 81(2):101-8. PubMed ID: 12708175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Letter: Double blind study of hydergine in aged patients].
    Paux G; Boismare F; Delaunay P
    Nouv Presse Med; 1975 Oct; 4(35):2529. PubMed ID: 812060
    [No Abstract]   [Full Text] [Related]  

  • 31. Ergoloid mesylates and ECT.
    Sachs GS; Gelenberg AJ; Bellinghausen B; Wojcik J; Falk WE; Farhadi AM; Jenike M
    J Clin Psychiatry; 1989 Mar; 50(3):87-90. PubMed ID: 2647711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Sickle cell disease and retinal damage: a study of 38 cases at the African Tropical Ophthalmology Institute (IOTA) in Bamako].
    Traoré J; Boitre JP; Bogoreh IA; Traoré L; Diallo A
    Med Trop (Mars); 2006 Jun; 66(3):252-4. PubMed ID: 16924816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Sickle cell priapism. Therapeutic considerations in the light of 23 cases (author's transl)].
    Tshipeta ; Lufuma
    J Urol (Paris); 1980; 86(9):699-702. PubMed ID: 7205020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydergine for schizophrenia.
    Cohen MR; Pary R; Burns R
    J Clin Psychiatry; 1987 Jan; 48(1):39-40. PubMed ID: 3542983
    [No Abstract]   [Full Text] [Related]  

  • 35. [Therapy of organic psychosyndrome with hydergine and digitalis. A component study using double blind technics].
    Pfeiff E; Schlegel HE; Seus R; Dennler HJ; Kugler J
    Med Welt; 1980 Sep; 31(39):1403-7. PubMed ID: 7005587
    [No Abstract]   [Full Text] [Related]  

  • 36. [Markers of lipid peroxidation, inflammatory proteins and plasma tocopherols in homozygotic and heterozygotic sickle cell anemia].
    Sess ED; Carbonneau MA; Meïté M; Peuchant E; Dumont MF; Receveur MC; Thomas MJ; Perromat A; Sangaré A; Le Bras M; Clerc M
    Bull Soc Pathol Exot; 1998; 91(3):238-41. PubMed ID: 9773200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Controlled clinical study of use of dihydroergocristine in cerebral and periferal vascular disorders].
    Calisti G; Biscarini L; Miseo A
    Clin Ter; 1977 Nov; 83(4):371-86. PubMed ID: 414875
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical evaluation of letosteine activity in the treatment of acute febrile bronchitis in children. Double-blind controlled study versus placebo].
    Nespoli L; Monafo V; Bonetti F; Terracciano L; Savio G
    Minerva Pediatr; 1989 Oct; 41(10):515-20. PubMed ID: 2693929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dihydroergocryptine in the management of senile psycho-organic syndrome.
    Scarzella L; Bono G; Bergamasco B
    Int J Clin Pharmacol Res; 1992; 12(1):37-46. PubMed ID: 1526697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prevention of drepanocytic painful crises with hydergine].
    Cuisinier JC; Ducloux M; Lagarde B; Barbotin M; Darracq R
    Bull Soc Med Afr Noire Lang Fr; 1974; 19(2):168-72. PubMed ID: 4219596
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.